TELA Bio, Inc. (TELA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 8M 16M 24M Q3 '21: 7.7M Q4 '21: 8.4M Q1 '22: 8.2M Q2 '22: 10.4M Q3 '22: 11.2M Q4 '22: 11.6M Q1 '23: 11.9M Q2 '23: 14.5M Q3 '23: 15.1M Q4 '23: 17M Q1 '24: 16.6M Q2 '24: 16.1M Q3 '24: 19M Q4 '24: 17.6M Q1 '25: 18.5M Q2 '25: 20.2M Q3 '25: 20.7M Q4 '25: 20.9M Q1 '26: 19.1M Q2 '26: 19.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 5M 10M 15M Q3 '21: 4.6M Q4 '21: 5.7M Q1 '22: 5M Q2 '22: 6.5M Q3 '22: 7.3M Q4 '22: 8.2M Q1 '23: 7.9M Q2 '23: 10.2M Q3 '23: 10.4M Q4 '23: 11.6M Q1 '24: 11.3M Q2 '24: 11.1M Q3 '24: 12.9M Q4 '24: 11.2M Q1 '25: 12.5M Q2 '25: 14.1M Q3 '25: 14M Q4 '25: 13.8M Q1 '26: 12.5M Q2 '26: 13.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -7.2M Q4 '21: -7.7M Q1 '22: -9.8M Q2 '22: -10.2M Q3 '22: -9.5M Q4 '22: -9.4M Q1 '23: -11.3M Q2 '23: -10.4M Q3 '23: -10.2M Q4 '23: -12.3M Q1 '24: -4.8M Q2 '24: -11.6M Q3 '24: -9.4M Q4 '24: -8.4M Q1 '25: -10.5M Q2 '25: -9.1M Q3 '25: -7.6M Q4 '25: -6.6M Q1 '26: -10.5M Q2 '26: -9.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -8.3M Q4 '21: -8.6M Q1 '22: -10.9M Q2 '22: -12.7M Q3 '22: -10.7M Q4 '22: -10M Q1 '23: -12M Q2 '23: -10.8M Q3 '23: -11M Q4 '23: -12.9M Q1 '24: -5.7M Q2 '24: -12.6M Q3 '24: -10.4M Q4 '24: -9.2M Q1 '25: -11.3M Q2 '25: -9.9M Q3 '25: -8.6M Q4 '25: -9M Q1 '26: -12.3M Q2 '26: -11.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q3 '21: 3M Q4 '21: 2.6M Q1 '22: 3.2M Q2 '22: 3.3M Q3 '22: 3.7M Q4 '22: 3.4M Q1 '23: 3.9M Q2 '23: 4.2M Q3 '23: 4.6M Q4 '23: 5.3M Q1 '24: 5.2M Q2 '24: 4.9M Q3 '24: 6M Q4 '24: 6.3M Q1 '25: 5.9M Q2 '25: 6M Q3 '25: 6.6M Q4 '25: 7M Q1 '26: 6.4M Q2 '26: 5.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -6.6M Q4 '21: -9.6M Q1 '22: -10.4M Q2 '22: -11.7M Q3 '22: -7.6M Q4 '22: -11M Q1 '23: -11.6M Q2 '23: -11.3M Q3 '23: -7M Q4 '23: -11.1M Q1 '24: -14.4M Q2 '24: -10.7M Q3 '24: -9M Q4 '24: -7.5M Q1 '25: -9.7M Q2 '25: -7.9M Q3 '25: -5.7M Q4 '25: -4.9M Q1 '26: -11.2M Q2 '26: -9.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -6.9M Q4 '21: -9.9M Q1 '22: -10.8M Q2 '22: -11.9M Q3 '22: -7.9M Q4 '22: -11M Q1 '23: -11.7M Q2 '23: -11.4M Q3 '23: -7.1M Q4 '23: -11.3M Q1 '24: -14.7M Q2 '24: -11M Q3 '24: -9.1M Q4 '24: -7.8M Q1 '25: -9.8M Q2 '25: -8M Q3 '25: -5.9M Q4 '25: -5M Q1 '26: -11.3M Q2 '26: -9.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 14.4M Q2 '21: 14.5M Q3 '21: 14.5M Q1 '22: 14.5M Q2 '22: 14.6M Q3 '22: 16.8M Q1 '23: 19.2M Q2 '23: 23.2M Q3 '23: 24.5M Q1 '24: 24.6M Q2 '24: 24.7M Q3 '24: 24.7M Q1 '25: 45.3M Q2 '25: 45.4M Q3 '25: 45.4M Q1 '26: 57.3M Q2 '26: 57.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '21: -2.24 Q4 '21: -2.29 Q1 '22: -2.48 Q2 '22: -2.79 Q3 '22: -2.86 Q4 '22: -2.75 Q1 '23: -2.63 Q2 '23: -2.21 Q3 '23: -2.02 Q4 '23: -2.07 Q1 '24: -1.67 Q2 '24: -1.72 Q3 '24: -1.69 Q4 '24: -1.33 Q1 '25: -1.35 Q2 '25: -1.06 Q3 '25: -0.83 Q4 '25: -0.83 Q1 '26: -0.79 Q2 '26: -0.77 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.